Customize this page|
2
Votes
vote
New market research report on global ophthalmic lasersReportlinker.com announces that a new market research report is available in its catalogue: Reportlinker Adds Global Ophthalmic Lasers Industry ... |
|
0
Votes
vote
CEO of pSivida to discuss new technologies in retinal drug delivery at the San Diego Ophthalmic summitpSivida Corp, (NASDAQ:PSDV)(ASX:PSD)(FF:PSI), a leading drug delivery company, today announced that Dr. Paul Ashton, CEO, will lead a discussion on New Technologies in Retinal Drug Delivery at the 5th Annual Ophthalmic Drug Development and Delivery Summit to be held September 21-22, 2009 in San D... |
|
2
Votes
vote
GS-101 effective in inhibiting and regressing corneal neovascularisationGene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal ... |
